Delivery Order SPE2DB20D6037-SPE2DB22FD0GZ
- Not listed
- This is a delivery order award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $1,583.28 firm fixed-price contract is for the delivery of Omeprazole DR 10 mg capsules. The award is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program. This IDC enables the DLA to issue firm fixed-price delivery...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $2,111.04 contract is for the delivery of Omeprazole DR 10 mg capsules. DMS Pharmaceutical Group has a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program to provide a comprehensive range of pharmaceutical products, including branded and generic prescription drugs,...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract, valued at $1,002.80, is for the delivery of Omeprazole extended-release medication to support the medical supply needs of military healthcare facilities. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of branded and generic prescription drugs,...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,248.00, is for the delivery of 4,567,792,099 units of the drug Omeprazole DR 10 mg capsules. The contract has an ultimate completion date of March 28, 2025. DMS Pharmaceutical Group Inc. holds a larger indefinite delivery contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $1,583.28 firm fixed-price delivery order is for 4,568,311,491 units of Omeprazole DR 10 mg capsules. The contract has an ultimate completion date of May 21, 2025. DMS Pharmaceutical Group Inc. holds a significant $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the agency...
- This is a firm fixed-price delivery order contract awarded to DMS Pharmaceutical Group Inc., a woman-owned small business, by the Defense Logistics Agency (DLA). The $1,055.52 contract is for the delivery of 30-count capsules of Omeprazole DR 10 mg. The contract has an ultimate completion date of July 3, 2025. DMS Pharmaceutical Group Inc. is a pharmaceutical wholesaler that specializes in supplying a range of pharmaceutical products, including branded and generic prescription drugs,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Omeprazole DR 10 mg capsules, a prescription medication, with a ceiling value of $4,222.08 and a completion date of May 16, 2025. The contract is a firm fixed-price delivery order, without any set-aside designation. DMS Pharmaceutical Group holds a significant...
- This is a delivery order contract awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA) under the SPE2DB program. The contract, valued at $4,222.08, is for the delivery of Omeprazole DR 10 mg capsules. The contract is a firm fixed-price delivery order with an ultimate completion date of April 9, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA...
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order by the Defense Logistics Agency (DLA) on August 28, 2025, for Omeprazole DR 10 mg capsules (30-count units) with a ceiling value of $1,319.40. This firm fixed-price delivery order, which is set to be completed by August 29, 2025, represents a single procurement action under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the DLA....
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of Omeprazole DR 10 mg capsules, with an ultimate completion date of May 27, 2025 and a ceiling value of $2,111.04. DMS Pharmaceutical Group holds a significant single-award Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program,...
- SPE2DB20D6037Indefinite Delivery Contract
- SPE2DB20D6037-SPE2DB22FD0GZDelivery Order
This is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, by the Defense Logistics Agency (DLA). The $1,650.70 contract is for the delivery of 4,558,320,769 units of omeprazole delayed-release 20 mg capsules. The award is part of DMS Pharmaceutical Group's broader $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue delivery orders for a wide range of pharmaceutical items to support the medical supply needs of Department of Defense healthcare facilities worldwide. DMS Pharmaceutical Group has established itself as a key supplier in the federal pharmaceutical supply chain, providing both routine and critical medications through this IDC and other prime vendor contracts. The contract has no set-aside designation. DMS Pharmaceutical Group's status as a woman-owned small business likely contributed to its selection for this direct award.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.7k | 9/2/22 |